Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hubert

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
ESMO Open|August 13, 2024
Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world dataB Brenner, K Shulman, A Hubert, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 21, 2021
Designing a Zn-Ag Catalyst Matrix and Electrolyzer System for CO<sub>2</sub> Conversion to CO and BeyondSarah Lamaison, David Wakerley, Frauke Kracke, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2008
Discovery of imidazole carboxamides as potent and selective CCK1R agonistsCheng Zhu, Alexa R Hansen, Thomas Bateman, et al.
Familial Cancer|April 10, 2021
A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancerI Kedar, L Walsh, G Reznick Levi, et al.
Microbiome|January 24, 2014
Multiphasic analysis of the temporal development of the distal gut microbiota in patients following ileal pouch anal anastomosisVincent B Young, Laura H Raffals, Susan M Huse, et al.
British Journal of Cancer|August 14, 2003
Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001)L Mauriac, E Luporsi, B Cutuli, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 13, 2002
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]A Fourquet, B Cutuli, E Luporsi, et al.
Nature Biomedical Engineering|June 11, 2025
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugatesBlaise R Kimmel, Karan Arora, Neil C Chada, et al.
Orphanet Journal of Rare Diseases|April 29, 2019
The natural history of classic galactosemia: lessons from the GalNet registryM E Rubio-Gozalbo, M Haskovic, A M Bosch, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
ESMO Open|August 13, 2024
Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world dataB Brenner, K Shulman, A Hubert, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 21, 2021
Designing a Zn-Ag Catalyst Matrix and Electrolyzer System for CO<sub>2</sub> Conversion to CO and BeyondSarah Lamaison, David Wakerley, Frauke Kracke, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2008
Discovery of imidazole carboxamides as potent and selective CCK1R agonistsCheng Zhu, Alexa R Hansen, Thomas Bateman, et al.
Familial Cancer|April 10, 2021
A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancerI Kedar, L Walsh, G Reznick Levi, et al.
Microbiome|January 24, 2014
Multiphasic analysis of the temporal development of the distal gut microbiota in patients following ileal pouch anal anastomosisVincent B Young, Laura H Raffals, Susan M Huse, et al.
British Journal of Cancer|August 14, 2003
Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001)L Mauriac, E Luporsi, B Cutuli, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 13, 2002
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]A Fourquet, B Cutuli, E Luporsi, et al.
Nature Biomedical Engineering|June 11, 2025
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugatesBlaise R Kimmel, Karan Arora, Neil C Chada, et al.
Orphanet Journal of Rare Diseases|April 29, 2019
The natural history of classic galactosemia: lessons from the GalNet registryM E Rubio-Gozalbo, M Haskovic, A M Bosch, et al.
Pageof 12